|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 26.20 EUR | -0.76% |
|
-1.50% | -5.76% |
| 05-29 | HAEMATO AG announces Annual dividend, payable on July 10, 2026 | CI |
| 01-31 | PHOENIX Pharmahandel SE completed the acquisition of HAEMATO Pharm GmbH from HAEMATO AG. | CI |
| Market Cap | 67.96M 77.48M 62.94M 57.91M 110M 7.42B 112M 750M 294M 3.64B 291M 285M 12.58B | P/E 2023 * |
-
| P/E 2024 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 67.96M 77.48M 62.94M 57.91M 110M 7.42B 112M 750M 294M 3.64B 291M 285M 12.58B | EV / Sales 2023 * |
-
| EV / Sales 2024 * | - |
| Free-Float |
99.67% | Yield 2023 * |
-
| Yield 2024 * | - |
| 1 day | -0.76% |
| Manager | Title | Age | Since |
|---|---|---|---|
Patrick Brenske
CEO | Chief Executive Officer | - | 30/11/2020 |
Attila Strauss
PRN | Corporate Officer/Principal | - | 01/04/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Andrea Grosse
CHM | Chairman | 61 | 30/05/2013 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.76% | -1.50% | - | - | 77.69M | |
| -0.11% | -2.66% | +47.50% | +16.07% | 305B | |
| +0.11% | -2.07% | +27.31% | -6.05% | 69.44B | |
| -0.41% | -5.59% | +32.29% | +94.50% | 9.04B | |
| -0.42% | -1.26% | +6.05% | +2.14% | 8.56B | |
| -3.76% | -8.00% | -19.33% | +7.60% | 4.3B | |
| -2.06% | -11.52% | +11.75% | +27.07% | 4.09B | |
| -0.58% | -3.27% | -39.03% | +20.58% | 3.4B | |
| -2.19% | +0.28% | +39.49% | +56.39% | 2.81B | |
| +0.49% | -1.85% | +10.78% | -21.01% | 2.14B | |
| Average | -0.95% | -2.62% | +12.98% | +21.92% | 45.43B | |
| Weighted average by Cap. | -0.14% | -4.37% | +40.84% | +13.90% |
| 2023 * | 2024 * | |
|---|---|---|
| Net sales | - | - |
| Net income | - | - |
| Net Debt | - | - |
Employees
-
Sector
Pharmaceuticals
- Stock Market
- Stocks
- HAEK Stock
- HAE Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
